Elizabeth A. Mittendorf

Also affiliated with Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Brigham Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592

Top 100%

0DataRank

Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Papers

Driven by 47 papers — median percentile 0. Top paper: “Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer”.

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0144

N/A

2.0DataRank · unranked

79 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z

N/A

1.8DataRank · unranked

48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3100

N/A

1.3DataRank · unranked

42 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005119

N/A

1.2DataRank · unranked

39 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Gerburg M. Wulf, Edward T. Richardson +10 more

Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer

Therapeutic Advances in Medical Oncology(2022)10.1177/17588359221113269

N/A

0.672DataRank · unranked

15 citations

Jennifer L. Guerriero, Sergey Naumenko, Shom Goel, Meredith M. Regan, Jiani Hu +10 more

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711

N/A

0.596DataRank · unranked

15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Use of Murine Models to Identify Tumor Immune Components that Correlate with Response to Immunotherapy in Breast Cancer

Research Square(2020)10.21203/rs.3.rs-57679/v1

N/A

0DataRank · unranked

0 citations

Anita K. Mehta, Emily Cheney, Eric P. Miller, Alaba Sotayo, Elizabeth A. Mittendorf +3 more

The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1

UNC Libraries(2020)10.17615/7kv3-8q30

N/A

0DataRank · unranked

0 citations

Kathryn Ruisaard, Karen Clise-Dwyer, Yoko Ono, Eric Wieder, Lisa S. St. John +14 more

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

npj Breast Cancer(2021)10.1038/s41523-021-00287-9

N/A

0DataRank · unranked

51 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo Pastorello +11 more

Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine

Advanced Science(2021)10.1002/advs.202100166

N/A

0DataRank · unranked

35 citations

Zhaoqi Li, Xiaojun Xia, Jingxin Zhang, Jun Li, Haoran Liu +10 more

Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients

Annals of Surgical Oncology(2021)10.1245/s10434-020-09542-y

N/A

0DataRank · unranked

31 citations

Marion E. Scoggins, Henry M. Kuerer, Savitri Krishnamurthy, Wei Yang, Ayşegül A. Şahin +9 more

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

Breast Cancer Research(2021)10.1186/s13058-021-01448-1

N/A

0DataRank · unranked

18 citations

Madeline G Townsend, Anita K. Mehta, Madisson Oliwa, Eric D. Miller, Alaba Sotayo +5 more

Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling

medRxiv(2021)10.1101/2021.05.10.21256419

N/A

0DataRank · unranked

3 citations

Geoffrey V. Martin, Zhihui Wang, Bruna Corradetti, Mauro Ferrari, Nestor F. Esnaola +16 more

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

Research Square(2021)10.21203/rs.3.rs-57679/v2

N/A

0DataRank · unranked

2 citations

Anita K. Mehta, Madeline G Townsend, Madisson Oliwa, Eric D. Miller, Alaba Sotayo +5 more

Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer

Science Advances(2022)10.1126/sciadv.abo5224

N/A

0DataRank · unranked

29 citations

Michael W. Malloy, Gregory J. Goreczny, Isabelle C. Becker, Qiuchen Guo, Elizabeth A. Mittendorf +4 more

Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06667-4

N/A

0DataRank · unranked

26 citations

John C. Rasmussen, Sarah M. DeSnyder, Wendy A. Woodward, Wenyaw Chan, Eva M. Sevick‐Muraca +11 more

Association of metabolic risk factors with breast cancer survival in a population-based cohort.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12089

N/A

0DataRank · unranked

1 citations

Alexa Zimbalist, Bette J. Caan, Elizabeth A. Mittendorf, Deborah Dillon, Charles P. Quesenberry +2 more

Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study

Annals of Surgical Oncology(2023)10.1245/s10434-023-13267-z

N/A

0DataRank · unranked

19 citations

Elizabeth A. Mittendorf, Stephanie Downs‐Canner

Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts

Cancer(2023)10.1002/cncr.34750

N/A

0DataRank · unranked

15 citations

Olga Martínez‐Sáez, Adrienne G. Waks, Alison Laws, Monica McGrath, Paolo Tarantino +11 more

Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy

Annals of Surgical Oncology(2023)10.1245/s10434-023-14446-8

N/A

0DataRank · unranked

13 citations

Ginger Zhe Jin, Rachel A. Freedman, Mara A. Schonberg, Tari A. King, Elizabeth A. Mittendorf +1 more

Selecting Triple Negative Breast Cancer Patients for Immunotherapy

Surgical Oncology Clinics of North America(2023)10.1016/j.soc.2023.05.005

N/A

0DataRank · unranked

1 citations

Elizabeth A. Mittendorf, Stephanie Downs‐Canner

Quality Control for Single Cell Analysis of High-plex Tissue Profiles using CyLinter

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.01.565120

N/A

0DataRank · unranked

5 citations

Edward Novikov, Ziyuan Zhao, Tuulia Vallius, Janae Davis, Jia‐Ren Lin +6 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592

Top 100%

0DataRank

Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597.v1

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060.v1

Top 100%

0DataRank

Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060

Top 100%

0DataRank

Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

896 Characterizing macrophage heterogeneity in HR+/HER2- metastatic breast cancer reveals novel mechanisms of resistance

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0896

N/A

0DataRank · unranked

0 citations

Kenichi Shimada, Madeline G Townsend, Tianyu Li, Nabihah Tayob, Molly DiLullo +9 more

1485 Characterization of the hormone receptor-positive breast tumor microenvironment using single cell transcriptomics and multi-plex immunofluorescence

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1485

N/A

0DataRank · unranked

0 citations

Kenichi Shimada, Kelly F Zheng, Cheryl Gu, Yvonne X Cui, Jonathan M. Goldberg +6 more

Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0357

N/A

0DataRank · unranked

27 citations

Esther R. Ogayo, Adrienne M. Parsons, Elizabeth A. Mittendorf, Peter van Galen, Sandra S. McAllister +1 more

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆

ESMO Open(2024)10.1016/j.esmoop.2024.103973

N/A

0DataRank · unranked

12 citations

Danielle Brandes Zakon, Qingchun Jin, Ava Strahan, Melissa Grimm, Melissa E. Hughes +15 more

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

npj Breast Cancer(2024)10.1038/s41523-023-00605-3

N/A

0DataRank · unranked

10 citations

Jia‐Ren Lin, Ricardo Pastorello, Ziming Du, Yu-An Chen, Madeline G Townsend +17 more

Regional Variation in Deescalated Therapy in Older Adults With Early-Stage Breast Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.41152

N/A

0DataRank · unranked

4 citations

Tanujit Dey, Yu-Jen Chen, Rachel A. Freedman, Eliza H. Lorentzen, Tari A. King +3 more

Physician-level variation in axillary surgery in older adults with T1N0 hormone receptor-positive breast cancer: A retrospective population-based cohort study

Journal of Geriatric Oncology(2024)10.1016/j.jgo.2024.101795

N/A

0DataRank · unranked

2 citations

Ginger Zhe Jin, Rachel A. Freedman, Mara A. Schonberg, Tari A. King, Elizabeth A. Mittendorf +1 more

Cell Populations in Human Breast Cancers are Molecularly and Biologically Distinct with Age

Research Square(2024)10.21203/rs.3.rs-5167339/v1

N/A

0DataRank · unranked

3 citations

Adrienne Parsons, Esther Sauras-Colón, Milos Spasic, Busem Binboğa Kurt, Alexander Swarbrick +4 more

Cell populations in human breast cancers are molecularly and biologically distinct with age

Nature Aging(2025)10.1038/s43587-025-00984-1

N/A

0DataRank · unranked

10 citations

Esther Sauras-Colón, Meghana Manjunath, Hanyun Zhang, Julia Chen, Milos Spasic +8 more

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010430

N/A

0DataRank · unranked

14 citations

Noah Graham, Lestat R. Ali, Christina I. Herold, Jennifer Desrosiers, Khanh Do +13 more

The impact of breast radiotherapy on the tumor genome and immune ecosystem

Cell Reports(2025)10.1016/j.celrep.2025.115703

N/A

0DataRank · unranked

5 citations

Tuan M. Tran, Jianzhuo Li, Emi Sei, Shanshan Bai, Min Hu +22 more

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

Nature Communications(2025)10.1038/s41467-025-66659-y

N/A

0DataRank · unranked

2 citations

Adrienne G. Waks, Erica Pimenta, Breanna Titchen, Kevin Bi, Sabrina Y. Camp +16 more

Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy

ESMO Open(2025)10.1016/j.esmoop.2025.105568

N/A

0DataRank · unranked

1 citations

Qi Jin, Agepati S. Raghavendra, Danielle Brandes Zakon, Melissa Grimm, Melissa E. Hughes +16 more

Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.12.001

N/A

0DataRank · unranked

211 citations

Sushil Kumar, Peng Jiang, Jason W. Pyrdol, Angela E. Zou, Anže Godicelj +11 more

1270 APOE tumor-associated macrophages and CD4-DOCK4 T cells reveal distinct microenvironmental features in HER2-Low and HER2–0 hormone receptor-positive breast cancer

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.1270

N/A

0DataRank · unranked

0 citations

Daniel Michaud, Kenichi Shimada, Adam Nelson, Jingxin Fu, Stuart J. Schnitt +7 more

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05638-x

N/A

0DataRank · unranked

82 citations

Elizabeth A. Mittendorf, Diane F. Hale, John W. Myers, Kaitlin M. Peace, Doreen O. Jackson +16 more

Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3089

N/A

0DataRank · unranked

51 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers

Nature Communications(2020)10.1038/s41467-020-19141-w

N/A

0DataRank · unranked

23 citations

Amjad H. Talukder, Ivy Lai, Rebecca K. Davis, Héctor M. Álvarez, Hervé Tiriac +27 more

A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia

UNC Libraries(2020)10.17615/rbbs-6280

N/A

0DataRank · unranked

1 citations

Jeffrey J. Molldrem, Pariya Sukhumalchandra, Sally A. Hunsucker, Elizabeth A. Mittendorf, Kathryn Ruisaard +14 more

Alliance A151804: Establishment of a national biorepository to advance studies of immune-related adverse events.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3154

N/A

0DataRank · unranked

5 citations

Elad Sharon, Jennifer Le‐Rademacher, Erin Twohy, Tyler Zemla, Yujia Wen +8 more

Elizabeth A. Mittendorf

Indexed papers

Top data-sharing exemplar

Papers